{"altmetric_id":13493432,"counts":{"readers":{"mendeley":5,"citeulike":0,"connotea":0},"total":{"posts_count":27},"blogs":{"unique_users_count":1,"unique_users":[56272],"posts_count":1},"twitter":{"unique_users_count":20,"unique_users":["ineurocienciasa","GreenJournal","Cefaleasclinico","senelson13","NeurologyToday","ATP_CME","sarahneuro","microbleeds","meimicchi","EdinUniImaging","SusAriRiv","mendibe_mar","jaygeorge60","JOHEBAR","ClinNeuroLleida","Didier_Garza","ictuslleida","StrokeNeurol","DrFelipeSuarez","BibliotecaHUVH"],"posts_count":21},"facebook":{"unique_users_count":3,"unique_users":["116510845078689","193133835711","202556649324"],"posts_count":4},"googleplus":{"unique_users_count":1,"unique_users":["Jes\u00fas Porta-Etessam"],"posts_count":1}},"selected_quotes":["Neurology: Pro-brain natriuretic peptide linked w\/ silent cerebrovascular lesions","N-terminal pro-brain natriuretic peptide and subclinical brain small vessel disease #hvhebron #neuro @GreenJournal","Top story: N-terminal pro-brain natriuretic peptide and subclinical brain small\u2026 see more","Neurology: N-terminal pro-brain natriuretic peptide in plasma linked with silent cerebrovascular lesions"],"citation":{"abstract":"To study the association of N-terminal pro-brain natriuretic peptide (NT-proBNP) with several brain MRI markers of brain vascular disease in a sample of participants free of stroke and dementia.\nNT-proBNP plasma level was determined by means of a sandwich immunoassay method in a cohort study comprising 278 hypertensive patients. The presence of silent brain infarcts, brain microbleeds, enlarged perivascular spaces, and white matter hyperintensity volumes was assessed by brain MRI. We performed univariate and multivariate analyses to determine whether NT-proBNP was independently associated with these imaging markers, individually or combined.\nMedian age was 63 years, and 41.4% were women. NT-proBNP remained independently associated with silent brain infarcts (odds ratio [OR] per 1-SD increase in NT-proBNP 2.11, 95% confidence interval [CI] 1.44-3.10), brain microbleeds (OR 1.79, 95% CI 1.15-2.78), basal ganglia enlarged perivascular spaces (OR 1.55, 95% CI 1.12-2.15), and white matter hyperintensity volumes (\u03b2 1.60, 95% CI 0.47-2.74), even after controlling for vascular risk factors, cardiovascular risk, atrial fibrillation, previous heart disease, duration of hypertension, and preventive treatments. A score combining several imaging markers was also related to NT-proBNP levels (common OR per 1-SD increase 1.74, 95% CI 1.21-2.50).\nNT-proBNP is independently associated with silent cerebrovascular lesions and could be a surrogate marker of vascular brain damage in hypertension.","altmetric_jid":"4f6fa5ea3cf058f610005b59","authors":["Andrea Vilar-Bergua","Iolanda Riba-Llena","Anna Penalba","Luz Mar\u00eda Cruz","Joan Jim\u00e9nez-Balado","Joan Montaner","Pilar Delgado","Vilar-Bergua, Andrea","Riba-Llena, Iolanda","Penalba, Anna","Cruz, Luz Mar\u00eda","Jim\u00e9nez-Balado, Joan","Montaner, Joan","Delgado, Pilar"],"doi":"10.1212\/wnl.0000000000003423","endpage":"2539","first_seen_on":"2016-11-10T14:34:18+00:00","funders":["niehs"],"issns":["1526-632X","0028-3878"],"issue":"24","journal":"Neurology","last_mentioned_on":1481716698,"links":["http:\/\/www.neurology.org\/cgi\/content\/short\/WNL.0000000000003423v1?rss=1&utm_source=dlvr.it&utm_medium=twitter","http:\/\/www.neurology.org\/content\/early\/2016\/11\/09\/WNL.0000000000003423.short","http:\/\/www.neurology.org\/content\/early\/2016\/11\/09\/WNL.0000000000003423.short?rss=1&utm_source=dlvr.it&utm_medium=gplus","http:\/\/neurology.org\/lookup\/doi\/10.1212\/WNL.0000000000003423","https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27956564","http:\/\/www.neurology.org\/cgi\/content\/short\/WNL.0000000000003423v1?rss=1&utm_source=dlvr.it&utm_medium=facebook"],"pdf_url":"http:\/\/www.neurology.org\/content\/early\/2016\/11\/09\/WNL.0000000000003423.full.pdf","pmid":"27956564","pubdate":"2016-11-09T00:00:00+00:00","publisher":"Lippincott Williams & Wilkins","publisher_subjects":[{"name":"Clinical Sciences","scheme":"era"},{"name":"Neurosciences","scheme":"era"},{"name":"Cognitive Science","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"startpage":"10.1212\/WNL.0000000000003423","subjects":["neurology"],"title":"N-terminal pro-brain natriuretic peptide and subclinical brain small vessel disease","type":"article","volume":"87","mendeley_url":"http:\/\/www.mendeley.com\/research\/nterminal-probrain-natriuretic-peptide-subclinical-brain-small-vessel-disease-2"},"altmetric_score":{"score":22.8,"score_history":{"1y":22.8,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":22.8},"context_for_score":{"all":{"total_number_of_other_articles":7885400,"mean":6.6781117138083,"rank":344471,"this_scored_higher_than_pct":95,"this_scored_higher_than":7540666,"rank_type":"exact","sample_size":7885400,"percentile":95},"similar_age_3m":{"total_number_of_other_articles":234663,"mean":13.016440625239,"rank":20312,"this_scored_higher_than_pct":91,"this_scored_higher_than":214331,"rank_type":"exact","sample_size":234663,"percentile":91},"this_journal":{"total_number_of_other_articles":9445,"mean":14.032081109699,"rank":1017,"this_scored_higher_than_pct":89,"this_scored_higher_than":8427,"rank_type":"exact","sample_size":9445,"percentile":89},"similar_age_this_journal_3m":{"total_number_of_other_articles":300,"mean":44.665150501672,"rank":78,"this_scored_higher_than_pct":73,"this_scored_higher_than":221,"rank_type":"exact","sample_size":300,"percentile":73}}},"demographics":{"poster_types":{"member_of_the_public":17,"practitioner":3},"users":{"twitter":{"cohorts":{"Members of the public":17,"Practitioners (doctors, other healthcare professionals)":3}},"mendeley":{"by_status":{"Student  > Postgraduate":1,"Other":2,"Student  > Bachelor":1,"Lecturer > Senior Lecturer":1},"by_discipline":{"Medicine and Dentistry":5}}},"geo":{"twitter":{"US":4,"EG":1,"IT":1,"GB":1,"ES":3,"MX":1,"CL":1}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/ineurocienciasa\/statuses\/796722603469570048","license":"gnip","citation_ids":[13493432],"posted_on":"2016-11-10T14:34:05+00:00","author":{"name":"ineurociencias","image":"https:\/\/pbs.twimg.com\/profile_images\/704301199529525250\/OgenAz1A_normal.jpg","id_on_source":"ineurocienciasa","tweeter_id":"704276087791087616","geo":{"lt":null,"ln":null},"followers":70},"tweet_id":"796722603469570048"},{"url":"http:\/\/twitter.com\/GreenJournal\/statuses\/796722605508042752","license":"gnip","citation_ids":[13493432],"posted_on":"2016-11-10T14:34:06+00:00","author":{"name":"Neurology Journal","url":"http:\/\/www.aan.com\/go\/elibrary\/journal","image":"https:\/\/pbs.twimg.com\/profile_images\/474219235028107264\/2LOTXs2__normal.png","description":"Neurology is the most widely read and highly cited peer-reviewed neurology journal. It is the medical journal for the American Academy of Neurology.","id_on_source":"GreenJournal","tweeter_id":"59547205","geo":{"lt":44.97997,"ln":-93.26384,"country":"US"},"followers":25922},"tweet_id":"796722605508042752"},{"url":"http:\/\/twitter.com\/Cefaleasclinico\/statuses\/796722613909266432","license":"gnip","citation_ids":[13493432],"posted_on":"2016-11-10T14:34:08+00:00","author":{"name":"cefaleas clinico","image":"https:\/\/pbs.twimg.com\/profile_images\/644223526476644353\/vatj1xQc_normal.jpg","id_on_source":"Cefaleasclinico","tweeter_id":"3677631497","geo":{"lt":null,"ln":null},"followers":60},"tweet_id":"796722613909266432"},{"url":"http:\/\/twitter.com\/senelson13\/statuses\/796724376544702464","license":"gnip","rt":["GreenJournal"],"citation_ids":[13493432],"posted_on":"2016-11-10T14:41:08+00:00","author":{"name":"Sarah Nelson","image":"https:\/\/pbs.twimg.com\/profile_images\/636359231650697216\/EEHFE209_normal.jpg","description":"Neurointensivist tweeting primarily about critical care, neurocritical care, and stroke.","id_on_source":"senelson13","tweeter_id":"3343448774","geo":{"lt":null,"ln":null},"followers":122},"tweet_id":"796724376544702464"},{"url":"http:\/\/twitter.com\/NeurologyToday\/statuses\/797182174755700736","license":"gnip","citation_ids":[13493432],"posted_on":"2016-11-11T21:00:16+00:00","author":{"name":"Neurology Today","url":"http:\/\/www.neurotodayonline.com","image":"https:\/\/pbs.twimg.com\/profile_images\/474220858295078914\/vUs3O0B__normal.png","description":"The official news source of the American Academy of Neurology, published by Wolters Kluwer.","id_on_source":"NeurologyToday","tweeter_id":"21938868","geo":{"lt":44.97997,"ln":-93.26384,"country":"US"},"followers":31377},"tweet_id":"797182174755700736"},{"url":"http:\/\/twitter.com\/ATP_CME\/statuses\/797209285889556480","license":"gnip","citation_ids":[13493432],"posted_on":"2016-11-11T22:47:59+00:00","author":{"name":"ATP EGYPT","url":"http:\/\/on.fb.me\/fJI2cE","image":"https:\/\/pbs.twimg.com\/profile_images\/1337289872\/DSCF1510_normal.JPG","description":"Abbassia Training Program (ATP) is an evolving psychiatric training program in Cairo. It arises from one of the archaic mental health hospitals in Middle East.","id_on_source":"ATP_CME","tweeter_id":"271494220","geo":{"lt":30.06263,"ln":31.24967,"country":"EG"},"followers":266},"tweet_id":"797209285889556480"},{"url":"http:\/\/twitter.com\/sarahneuro\/statuses\/797219715206807554","license":"gnip","citation_ids":[13493432],"posted_on":"2016-11-11T23:29:26+00:00","author":{"name":"(((Sarah S.)))","image":"https:\/\/pbs.twimg.com\/profile_images\/650820418241208320\/3Yk1opHK_normal.jpg","description":"neurologist, working in hospital, dealing with life, death and people in between","id_on_source":"sarahneuro","tweeter_id":"3037715188","geo":{"lt":45.46427,"ln":9.18951,"country":"IT"},"followers":55},"tweet_id":"797219715206807554"},{"url":"http:\/\/twitter.com\/microbleeds\/statuses\/798777168423587840","license":"gnip","rt":["GreenJournal"],"citation_ids":[13493432],"posted_on":"2016-11-16T06:38:12+00:00","author":{"name":"Cerebral microbleeds","url":"http:\/\/microbleeds.org\/","image":"https:\/\/pbs.twimg.com\/profile_images\/628273216084164608\/7c8wHsmJ_normal.jpg","description":"International platform to share ideas and updates on microbleeds \u2013 an MRI marker of small vessel disease. #microbleeds Founded by @a_charidimou","id_on_source":"microbleeds","tweeter_id":"3401568807","geo":{"lt":42.35843,"ln":-71.05977,"country":"US"},"followers":1517},"tweet_id":"798777168423587840"},{"url":"http:\/\/twitter.com\/meimicchi\/statuses\/798797941032960000","license":"gnip","rt":["GreenJournal"],"citation_ids":[13493432],"posted_on":"2016-11-16T08:00:44+00:00","author":{"name":"\u30e1\u30a4","image":"https:\/\/pbs.twimg.com\/profile_images\/1463417003\/10007742308_normal.jpg","description":"\u8133\u795e\u7d4c\u3001\u8133\u5faa\u74b0\u3001\u8133\u8840\u7ba1\u3092\u5c02\u9580\u3068\u3057\u3066\u3044\u307e\u3059","id_on_source":"meimicchi","tweeter_id":"147578662","geo":{"lt":null,"ln":null},"followers":67},"tweet_id":"798797941032960000"},{"url":"http:\/\/twitter.com\/EdinUniImaging\/statuses\/798844116331204609","license":"gnip","rt":["GreenJournal"],"citation_ids":[13493432],"posted_on":"2016-11-16T11:04:13+00:00","author":{"name":"Edinburgh Imaging","url":"http:\/\/www.ed.ac.uk\/edinburgh-imaging","image":"https:\/\/pbs.twimg.com\/profile_images\/3498262817\/dd29406ce72a465596e50005c63d8bd3_normal.jpeg","description":"Edinburgh Imaging - a collaboration of scientists and doctors, advancing health through excellence in imaging science. http:\/\/www.ed.ac.uk\/edinburgh-imaging","id_on_source":"EdinUniImaging","tweeter_id":"1338987882","geo":{"lt":55.95206,"ln":-3.19648,"country":"GB"},"followers":1762},"tweet_id":"798844116331204609"},{"url":"http:\/\/twitter.com\/NeurologyToday\/statuses\/798918608747307008","license":"gnip","citation_ids":[13493432],"posted_on":"2016-11-16T16:00:14+00:00","author":{"name":"Neurology Today","url":"http:\/\/www.neurotodayonline.com","image":"https:\/\/pbs.twimg.com\/profile_images\/474220858295078914\/vUs3O0B__normal.png","description":"The official news source of the American Academy of Neurology, published by Wolters Kluwer.","id_on_source":"NeurologyToday","tweeter_id":"21938868","geo":{"lt":44.97997,"ln":-93.26384,"country":"US"},"followers":31377},"tweet_id":"798918608747307008"},{"url":"http:\/\/twitter.com\/SusAriRiv\/statuses\/798919788617547776","license":"gnip","rt":["NeurologyToday"],"citation_ids":[13493432],"posted_on":"2016-11-16T16:04:55+00:00","author":{"name":"Susana Arias","image":"https:\/\/abs.twimg.com\/sticky\/default_profile_images\/default_profile_normal.png","id_on_source":"SusAriRiv","tweeter_id":"4258248759","geo":{"lt":null,"ln":null},"followers":63},"tweet_id":"798919788617547776"},{"url":"http:\/\/twitter.com\/mendibe_mar\/statuses\/798920733527252992","license":"gnip","rt":["NeurologyToday"],"citation_ids":[13493432],"posted_on":"2016-11-16T16:08:40+00:00","author":{"name":"Mar Mendibe","image":"https:\/\/pbs.twimg.com\/profile_images\/658956386248892416\/u80RMCFC_normal.jpg","description":"Neurologist. MS specialist. Lecturer in Faculty of Medicine. Interested in brain, MS, healthcare manegement. Bilbao lover.","id_on_source":"mendibe_mar","tweeter_id":"4051889169","geo":{"lt":43.26271,"ln":-2.92528,"country":"ES"},"followers":339},"tweet_id":"798920733527252992"},{"url":"http:\/\/twitter.com\/jaygeorge60\/statuses\/798924586075029504","license":"gnip","rt":["NeurologyToday"],"citation_ids":[13493432],"posted_on":"2016-11-16T16:23:59+00:00","author":{"name":"Jay George","image":"https:\/\/pbs.twimg.com\/profile_images\/861414269711200256\/U0C4MNzY_normal.jpg","id_on_source":"jaygeorge60","tweeter_id":"1540643960","geo":{"lt":28.75054,"ln":-82.5001,"country":"US"},"followers":405},"tweet_id":"798924586075029504"},{"url":"http:\/\/twitter.com\/JOHEBAR\/statuses\/798946078343184384","license":"gnip","rt":["NeurologyToday"],"citation_ids":[13493432],"posted_on":"2016-11-16T17:49:23+00:00","author":{"name":"Jose Hermida","image":"https:\/\/pbs.twimg.com\/profile_images\/697402002779668481\/6SJvMgci_normal.jpg","id_on_source":"JOHEBAR","tweeter_id":"136861022","geo":{"lt":null,"ln":null},"followers":19},"tweet_id":"798946078343184384"},{"url":"http:\/\/twitter.com\/ClinNeuroLleida\/statuses\/798951702808252416","license":"gnip","rt":["NeurologyToday"],"citation_ids":[13493432],"posted_on":"2016-11-16T18:11:44+00:00","author":{"name":"ClinicNeuroscLleida","url":"http:\/\/clinicalneuroscienceslleida.wordpress.com","image":"https:\/\/pbs.twimg.com\/profile_images\/800076043486986240\/kIhVzSq-_normal.jpg","description":"Clinical Neurosciences Group is located at @Info_IRBLleida in cooperation with @harnaulleida. We are focused in the discovery of new stroke biomarkers.","id_on_source":"ClinNeuroLleida","tweeter_id":"4075573042","geo":{"lt":41.61674,"ln":0.62218,"country":"ES"},"followers":312},"tweet_id":"798951702808252416"},{"url":"http:\/\/twitter.com\/Didier_Garza\/statuses\/798981239893938176","license":"gnip","rt":["NeurologyToday"],"citation_ids":[13493432],"posted_on":"2016-11-16T20:09:06+00:00","author":{"name":"Dr Juan Didier Garza","image":"https:\/\/pbs.twimg.com\/profile_images\/809032560856571904\/fnZk3yYY_normal.jpg","description":"Neurologist. Love my job, music, cooking and dogs.\nGreen Bay Packers Fan.","id_on_source":"Didier_Garza","tweeter_id":"283371518","geo":{"lt":20.72356,"ln":-103.38479,"country":"MX"},"followers":112},"tweet_id":"798981239893938176"},{"url":"http:\/\/twitter.com\/ictuslleida\/statuses\/799008319264477187","license":"gnip","rt":["NeurologyToday"],"citation_ids":[13493432],"posted_on":"2016-11-16T21:56:42+00:00","author":{"name":"ictuslleida","image":"https:\/\/pbs.twimg.com\/profile_images\/537124852860071936\/53TxTPCh_normal.jpeg","id_on_source":"ictuslleida","tweeter_id":"2891674419","geo":{"lt":null,"ln":null},"followers":245},"tweet_id":"799008319264477187"},{"url":"http:\/\/twitter.com\/StrokeNeurol\/statuses\/799021070577639426","license":"gnip","rt":["NeurologyToday"],"citation_ids":[13493432],"posted_on":"2016-11-16T22:47:22+00:00","author":{"name":"\u5e83\u5357\u75c5\u9662 \u8133\u8840\u7ba1\u5185\u79d1@\u533b\u5e2b\u7d76\u8cdb\u52df\u96c6\u4e2d","url":"http:\/\/www.kohnan-sendai.or.jp","image":"https:\/\/pbs.twimg.com\/profile_images\/869753967164538880\/613Y-t-l_normal.jpg","description":"\u4ed9\u53f0\u306e\u8133\u5352\u4e2d\u5c02\u9580\u5185\u79d1\u3067\u3059\uff0e\u8840\u6813\u6eb6\u89e3\/\u7834\u7815\uff0c\u795e\u7d4c\u8d85\u97f3\u6ce2\uff0c\u795e\u7d4c\u5fc3\u7406\u5b66\uff0e\u533b\u5e2b\u7d76\u8cdb\u52df\u96c6\u4e2d.Dept.of Stroke Neurology, Kohnan Hosp, Sendai \/thrombolysis\/thrombectomy \/neurosonology\/behavioral Neurology","id_on_source":"StrokeNeurol","tweeter_id":"243953821","geo":{"lt":null,"ln":null},"followers":1173},"tweet_id":"799021070577639426"},{"url":"http:\/\/twitter.com\/DrFelipeSuarez\/statuses\/799799856978071552","license":"gnip","rt":["NeurologyToday"],"citation_ids":[13493432],"posted_on":"2016-11-19T02:22:00+00:00","author":{"name":"Felipe Su\u00e1rez","image":"https:\/\/pbs.twimg.com\/profile_images\/733838861990821888\/uTv4gO-7_normal.jpg","id_on_source":"DrFelipeSuarez","tweeter_id":"3942369442","geo":{"lt":-40.57395,"ln":-73.13348,"country":"CL"},"followers":34},"tweet_id":"799799856978071552"},{"url":"http:\/\/twitter.com\/BibliotecaHUVH\/statuses\/809004567597871104","license":"gnip","citation_ids":[13493432],"posted_on":"2016-12-14T11:58:14+00:00","author":{"name":"BibliotecaHUVH. ICS","url":"http:\/\/www.vhebron.net","image":"https:\/\/pbs.twimg.com\/profile_images\/875677660990636032\/7po0FDW5_normal.jpg","description":"Biblioteca Digital de l\u2019Hospital Universitari Vall d\u2019Hebron. Institut Catal\u00e0 de la Salut. Departament de Salut. Generalitat de Catalunya","id_on_source":"BibliotecaHUVH","tweeter_id":"124130301","geo":{"lt":41.38879,"ln":2.15899,"country":"ES"},"followers":2038},"tweet_id":"809004567597871104"}],"googleplus":[{"url":"https:\/\/plus.google.com\/114954907798289839539\/posts\/cBcE2nGuQfS","license":"public","citation_ids":[13493432],"posted_on":"2016-11-10T14:34:21+00:00","summary":"N-terminal pro-brain natriuretic peptide and subclinical brain small vessel disease Abstract Objective: To study the association of N-terminal pro-brain natriuretic peptide (NT-proBNP) with several brain MRI markers of brain vascular disease in a sample of","author":{"name":"Jes\u00fas Porta-Etessam","url":"https:\/\/plus.google.com\/114954907798289839539","image":"https:\/\/lh4.googleusercontent.com\/-eNGY3zMQQhc\/AAAAAAAAAAI\/AAAAAAAAACQ\/h7ubzIIWcBU\/photo.jpg?sz=50","id_on_source":"114954907798289839539"}}],"blogs":[{"title":"N-terminal pro-brain natriuretic peptide and subclinical brain small vessel disease","url":"http:\/\/www.neurology.org\/cgi\/content\/short\/87\/24\/2533?rss=1","license":"public","citation_ids":[13493432],"posted_on":"2016-12-12T20:45:00+00:00","summary":"Objective:To study the association of N-terminal pro-brain natriuretic peptide (NT-proBNP) with several brain MRI markers of brain vascular disease in a sample of participants free of stroke and dementia.\nMethods:NT-proBNP plasma level was determined by me","author":{"name":"Neurology current issue","url":"http:\/\/www.neurology.org\/","description":"Neurology RSS feed -- current issue"}}],"facebook":[{"title":"N-terminal pro-brain natriuretic peptide and subclinical brain small vessel disease. - PubMed - NCBI","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=1285567084839720&id=116510845078689","license":"public","citation_ids":[13493432],"posted_on":"2016-12-14T11:58:18+00:00","summary":"N-terminal pro-brain natriuretic peptide and subclinical brain small vessel disease https:\/\/t.co\/vtsxGTKtIY #hvhebron #neuro @GreenJournal","author":{"name":"Biblioteca Digital de l'Hospital Universitari Vall d'Hebron. ICS","url":"https:\/\/www.facebook.com\/116510845078689","facebook_wall_name":"Biblioteca Digital de l'Hospital Universitari Vall d'Hebron. ICS","image":"https:\/\/graph.facebook.com\/116510845078689\/picture","id_on_source":"116510845078689"}},{"title":"N-terminal pro-brain natriuretic peptide and subclinical brain small vessel disease","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=10154782251120712&id=193133835711","license":"public","citation_ids":[13493432],"posted_on":"2016-11-16T16:00:08+00:00","summary":"Pro-brain natriuretic peptide was associated with silent cerebrovascular lesions on MRI, according to a new study published online on November 9 in Neurology. The findings suggest the peptide \u201ccould be a surrogate marker of vascular brain damage in hyperte","author":{"name":"Neurology Today","url":"https:\/\/www.facebook.com\/193133835711","facebook_wall_name":"Neurology Today","image":"https:\/\/graph.facebook.com\/193133835711\/picture","id_on_source":"193133835711"}},{"title":"N-terminal pro-brain natriuretic peptide and subclinical brain small vessel disease","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=10154765668965712&id=193133835711","license":"public","citation_ids":[13493432],"posted_on":"2016-11-11T21:00:20+00:00","summary":"N-terminal pro-brain natriuretic peptide in plasma was associated with silent cerebrovascular lesions on brain MRI, according to a new study published online on November 7 in Neurology. The findings suggest the peptide \u201ccould be a surrogate marker of vascu","author":{"name":"Neurology Today","url":"https:\/\/www.facebook.com\/193133835711","facebook_wall_name":"Neurology Today","image":"https:\/\/graph.facebook.com\/193133835711\/picture","id_on_source":"193133835711"}},{"title":"N-terminal pro-brain natriuretic peptide and subclinical brain small vessel disease","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=10155352435009325&id=202556649324","license":"public","citation_ids":[13493432],"posted_on":"2016-11-10T14:34:29+00:00","summary":"Objective:\n\nTo study the association of N-terminal pro-brain natriuretic peptide (NT-proBNP) with several brain MRI markers of brain vascular disease in a sample of participants free of stroke and dementia.Methods:\n\nNT-proBNP plasma level was determined by","author":{"name":"Neurology Journal","url":"https:\/\/www.facebook.com\/202556649324","facebook_wall_name":"Neurology Journal","image":"https:\/\/graph.facebook.com\/202556649324\/picture","id_on_source":"202556649324"}}]}}